158 results on '"Dery, Jean-Pierre"'
Search Results
2. Rationale and design for the myocardial ischemia and transfusion (MINT) randomized clinical trial
3. Transradial experience with bioresorbable vascular scaffolds: A case-matched study with metallic drug-eluting stents
4. A Randomized Double-Blind Placebo-Controlled Study Comparing Intracoronary Versus Intravenous Abciximab in Patients With ST-Elevation Myocardial Infarction Undergoing Transradial Rescue Percutaneous Coronary Intervention After Failed Thrombolysis
5. Recurrent Cardiovascular Events in Survivors of Myocardial Infarction With ST-Segment Elevation (from the AMI-QUEBEC Study)
6. 2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet Therapy
7. Feasibility and Safety of Early Repeat Transradial Access Within 30 Days of Previous Coronary Angiography and Intervention
8. Longitudinal treatment patterns with ADP receptor inhibitors after myocardial infarction: Insights from the Canadian Observational AntiPlatelet sTudy
9. Antithrombotic Therapies in Canadian Atrial Fibrillation Patients with Concomitant Coronary Artery Disease: Insights from the CONNECT AF+PCI-II Program
10. Cardiovascular Risk Factors and In-hospital Mortality in Acute Coronary Syndromes: Insights From the Canadian Global Registry of Acute Coronary Events
11. Effectiveness of Low Rate Fluoroscopy at Reducing Operator and Patient Radiation Dose During Transradial Coronary Angiography and Interventions
12. Contemporary use of guideline‐based higher potency P2Y12 receptor inhibitor therapy in patients with moderate‐to‐high risk non‐ST‐segment elevation myocardial infarction: Results from the Canadian ACS reflective II cross‐sectional study
13. Risk Score, Causes, and Clinical Impact of Failure of Transradial Approach for Percutaneous Coronary Interventions
14. Interaction of Chronic Total Occlusion and Chronic Kidney Disease in Patients Undergoing Primary Percutaneous Coronary Intervention for Acute ST-Elevation Myocardial Infarction
15. Effect on Door-to-Balloon Time of Immediate Transradial Percutaneous Coronary Intervention on Culprit Lesion in ST-Elevation Myocardial Infarction Compared to Diagnostic Angiography Followed by Primary Percutaneous Coronary Intervention
16. Benefit of Bivalirudin Versus Heparin After Transradial and Transfemoral Percutaneous Coronary Intervention
17. Relation Between Previous Angiotensin-Converting Enzyme Inhibitor Use and In-Hospital Outcomes in Acute Coronary Syndromes
18. Importance of Diffuse Atherosclerosis in the Functional Evaluation of Coronary Stenosis in the Proximal-Mid Segment of a Coronary Artery by Myocardial Fractional Flow Reserve Measurements
19. Provision of a DAPT Score to Cardiologists and Extension of Dual Antiplatelet Therapy Beyond 1 Year After ACS: Randomized Substudy of the Prospective Canadian ACS Reflective II Study
20. Antithrombotic Therapy After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation: Findings From the CONNECT AF+PCI Study
21. Safety and effectiveness of enoxaparin following fibrinolytic therapy: Results of the Acute Myocardial Infarction (AMI)-QUEBEC registry
22. Impact of thrombus aspiration on angiographic and clinical outcomes in patients with ST-elevation myocardial infarction
23. Incidence, Range, and Clinical Effect of Hemoglobin Changes Within 24 Hours After Transradial Coronary Stenting
24. Intracoronary Compared to Intravenous Abciximab and High-Dose Bolus Compared to Standard Dose in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Transradial Primary Percutaneous Coronary Intervention: a Two-by-Two Factorial Placebo-Controlled Randomized Study
25. Management patterns of non-ST segment elevation acute coronary syndromes in relation to prior coronary revascularization
26. Use of antithrombotic therapy for secondary prevention in patients with stable atherosclerotic cardiovascular disease: Insights from the COordinated National Network to Engage Cardiologists in the antithrombotic Treatment of patients with CardioVascular Disease (CONNECT‐CVD) study
27. Effects of intracoronary compared to intravenous abciximab administration in patients undergoing transradial percutaneous coronary intervention: A sub-analysis of the EASY trial
28. Usefulness of Coronary Fractional Flow Reserve Measurements in Guiding Clinical Decisions in Intermediate or Equivocal Left Main Coronary Stenoses
29. Impact of fractional flow reserve measurement on the clinical management of patients with coronary artery disease evaluated with noninvasive stress tests prior to cardiac catheterization
30. One-year clinical outcome after abciximab bolus-only compared with abciximab bolus and 12-hour infusion in the Randomized EArly Discharge after Transradial Stenting of CoronarY Arteries (EASY) Study
31. Outpatient percutaneous coronary intervention: Ready for prime time?
32. Treatment delays in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction at the Quebec Heart and Lung Institute
33. Predictors of Aorto–Saphenous Vein Bypass Narrowing Late After Coronary Artery Bypass Grafting
34. Canada Acute Coronary Syndrome Risk Score: A new risk score for early prognostication in acute coronary syndromes
35. Highlights from the american college of cardiology annual scientific sessions 2003: March 28 to April 2, 2003
36. Usefulness of Fractional Flow Reserve Measurements to Defer Revascularization in Patients With Stable or Unstable Angina Pectoris, Non–ST-Elevation and ST-Elevation Acute Myocardial Infarction, or Atypical Chest Pain
37. Complementary Effects of Thienopyridine Pretreatment and Platelet Glycoprotein IIb/IIIa Integrin Blockade With Eptifibatide in Coronary Stent Intervention; Results From the ESPRIT Trial
38. Time to reperfusion therapy
39. Highlights from the American College of Cardiology Annual Scientific Sessions 2004: March 9–12, 2004
40. Highlights from the American Heart Association Annual Scientific Sessions 2003: November 9 to 12, 2003
41. Highlights from the American Heart Association Annual Scientific Sessions 2002: November 17 to 20, 2002
42. RACIAL DISPARITIES IN ACUTE CORONARY SYNDROME MANAGEMENT WITHIN THE CANADIAN UNIVERSAL HEALTHCARE SYSTEM: INSIGHTS FROM THE AMI-OPTIMA TRIAL
43. Impact of an invasive strategy in the elderly hospitalized with acute coronary syndrome with emphasis on the nonagenarians
44. INDEPENDENT PREDICTORS OF LIPID-LOWERING THERAPY INTENSIFICATION AMONG PATIENTS HOSPITALIZED FOR AN ACUTE CORONARY SYNDROME: INSIGHTS FROM THE AMI-OPTIMA STUDY
45. KNOWLEDGE TRANSLATION TO IMPROVE PRESCRIPTION OF EVIDENCE-BASED MEDICAL THERAPY FOR PATIENTS ADMITTED WITH ACUTE CORONARY SYNDROMES: INSIGHTS FROM THE AMI-OPTIMA STUDY
46. KNOWLEDGE TRANSLATION TO REDUCE DELAYS OF PRIMARY PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH MYOCARDIAL INFARCTION WITH ST-SEGMENT ELEVATION: INSIGHTS FROM THE AMI-ON TIME STUDY
47. Increased Uptake of Guideline-Recommended Oral Antiplatelet Therapy: Insights from the Canadian Acute Coronary Syndrome Reflective
48. Eptifibatide in Coronary Intervention: The IMPACT and ESPRIT Trials
49. Vorapaxar in Acute Coronary Syndrome Patients Undergoing Coronary Artery Bypass Graft Surgery
50. Effects of vorapaxar on platelet reactivity and biomarker expression in non-ST-elevation acute coronary syndromes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.